[{"Assets_0_Q2_USD":579000000.0,"CommonStockSharesOutstanding_0_Q2_shares":38156959.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-73921000.0,"NetIncomeLoss_1_Q2_USD":-17701000.0,"NetIncomeLoss_2_Q2_USD":-53085000.0,"StockholdersEquity_0_Q2_USD":486976000.0,"Ticker":"PRTA","CIK":"1559053","name":"PROTHENA CORP PLC","OfficialName":"Prothena Corporation plc Ordinary Shares","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1633142175.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]